Results 221 to 230 of about 299,295 (343)
Efficacy and Safety of the Sync‐AV II Temporary Cardiac Pacing Catheter (EASY II Trial)
ABSTRACT Background Cardiac pacing is crucial for patients with hemodynamically unstable bradyarrhythmias. For most indications, transvenous pacemakers are used to pace the right ventricle, causing atrioventricular dyssynchrony, which may lead to significant hemodynamic compromise.
Som A. Bailey +5 more
wiley +1 more source
Impact of myocardial perfusion abnormalities on clinical outcomes in patients treated with percutaneous coronary intervention for chronic total occlusions. [PDF]
Henningsen JB +13 more
europepmc +1 more source
ABSTRACT Tanshinones, the major bioactive diterpenes in Salvia miltiorrhiza Bunge, are widely used to treat cardiovascular and cerebrovascular diseases. While jasmonates (JAs) are known to modulate tanshinones accumulation, the molecular link between JA signalling and tanshinone biosynthesis remains unclear.
Renjun Qu +9 more
wiley +1 more source
Device-Based Therapies for Refractory Angina. [PDF]
Caffè A, Montone RA.
europepmc +1 more source
Treatment of chronic refractory angina pectoris—light at the end of the tunnel?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology. [PDF]
Jan Erik Nordrehaug, Mohamed L. Salem
openalex +1 more source
ABSTRACT Objective This study explored barriers to cardiovascular rehabilitation (CR) participation among individuals with cardiovascular disease (CVD) and risk factors in a rural, low‐resource setting. Design A qualitative study using focus groups. Sample 21 individuals (76% women, 71% with CVD risk factors, 48% with incomplete elementary education ...
Mayara Moura Alves da Cruz +7 more
wiley +1 more source
Integrated Assessment of Drugs and Interventional Devices in the Management of Acute Myocardial Infarction, Refractory Angina, and Heart Failure: A Clinical Outcome-Based Study. [PDF]
Akhtar F +3 more
europepmc +1 more source

